Literature DB >> 9108657

Citalopram and desmethylcitalopram concentrations in breast milk and in serum of mother and infant.

P N Jensen1, O V Olesen, A Bertelsen, K Linnet.   

Abstract

A case is presented with measurements of the selective serotonin reuptake inhibitor (SSRI)-antidepressant citalopram in serum of mother and breast-fed infant and in breast milk. We found a milk-to-serum concentration ratio of approximately 3 for both citalopram and the main metabolite desmethylcitalopram. Peak milk concentrations of citalopram occurred 3-9 h after drug intake by the mother. The infant received approximately 5% of the mother's dose, adjusted for weight. Accordingly, the serum level in the infant of approximately 7 nM corresponded to approximately 1/15 of the trough serum concentration of the mother (104 nM). No signs of drug effects in the infant were observed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9108657     DOI: 10.1097/00007691-199704000-00021

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  12 in total

Review 1.  Antidepressants and breast-feeding: a review of the literature.

Authors:  S Dodd; A Buist; T R Norman
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

Review 2.  Neonatal exposure to drugs in breast milk.

Authors:  Patrick J McNamara; Maggie Abbassi
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

Review 3.  Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index.

Authors:  Salvatore Gentile
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

4.  Transfer of escitalopram and its metabolite demethylescitalopram into breastmilk.

Authors:  Jonathan Rampono; L Peter Hackett; Judith H Kristensen; Rolland Kohan; Madhu Page-Sharp; Kenneth F Ilett
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

Review 5.  Benefits and risks to mother and infant of drug treatment for postnatal depression.

Authors:  Shaila Misri; Xanthoula Kostaras
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

6.  Citalopram and demethylcitalopram in human milk; distribution, excretion and effects in breast fed infants.

Authors:  J Rampono; J H Kristensen; L P Hackett; M Paech; R Kohan; K F Ilett
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

Review 7.  Treating recurrent affective disorders during and after pregnancy. What can be taken safely?

Authors:  M Schou
Journal:  Drug Saf       Date:  1998-02       Impact factor: 5.606

Review 8.  The safety of newer antidepressants in pregnancy and breastfeeding.

Authors:  Salvatore Gentile
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 9.  Use of psychotropic medications in treating mood disorders during lactation : practical recommendations.

Authors:  Malin Eberhard-Gran; Anne Eskild; Stein Opjordsmoen
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

10.  Antidepressant transfer into amniotic fluid, umbilical cord blood & breast milk: A systematic review & combined analysis.

Authors:  Georgios Schoretsanitis; Andreas A Westin; Julia C Stingl; Kristina M Deligiannidis; Michael Paulzen; Olav Spigset
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-01-02       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.